PRMT1 gene expression is substantially higher in breast tumor samples than in healthy breast tissues, and several studies evidence its role in regulating the metastatic potential of breast cancer, as well as therapy efficacy [11,12]. Here, PRMT1 is linked to breast carcinoma.